Calcium antagonists as first-choice therapy for low-renin essential hypertension.
Bühler
F R
FR
Department of Research, University Hospital, Basel, Switzerland.
D000959:Antihypertensive Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002319:Cardiovascular System / Q000503:physiopathology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000201:enzymology / Q000503:physiopathology; D007668:Kidney / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D009568:Nitrendipine / Q000627:therapeutic use; D012083:Renin / Q000097:blood*; D014700:Verapamil / Q000627:therapeutic use
D000959:Antihypertensive Agents; D015415:Biomarkers; D002121:Calcium Channel Blockers; D009568:Nitrendipine; D014700:Verapamil; D012083:Renin